Autoantibodies to Endothelial Cells

  • Jeremy D. Pearson
Part of the NATO ASI Series book series (NSSA, volume 208)


It has become apparent over the last 10 years that anti-endothelial cell antibodies (AECA) are present in a proportion of patients with a wide variety of autoimmune diseases that exhibit vascular pathology. These antibodies have, in general, been detected in one of two ways: by their ability to kill endothelial cells (EC) in vitro in the presence of complement or by their ability to bind to cultured EC monolayers and are therefore presumed to recognize antigens at the surface of EC.


Systemic Lupus Erythematosus Kawasaki Disease Systemic Sclerosis Hemolytic Uremic Syndrome Mixed Connective Tissue Disease 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Alderuccio, F., Barnett, A.J., Campbell, J.H., Pedersen, J.S. and Toh, B.H. Scl-95/100; doublet of endothelial marker autoantigens in progressive systemic sclerosis. Clin. Exp. Immunol. 64: 94–100, 1986.PubMedGoogle Scholar
  2. Awada, H., Barlowatz-Meimon, G., Dougados, M., Maisonneuve, P., Sultan, Y. and Amor, B. Fibrinolysis abnormalities in systemic lupus erythematosus and their relation to vasculitis. J. Lab. Clin. Med 111: 229–236, 1988.PubMedGoogle Scholar
  3. Baguley, E. and Hughes, G.R.V. Lytic IgG anti-endothelial cell antibodies in vasculitis. Lancet ii: 907, 1988.CrossRefGoogle Scholar
  4. Belch, J.J.F., Zoma, A., McLaughlin, K., Curran, L., Capell, H.A., Forbes, C.D. and Sturrock, R.D. Fibrinolysis in systemic lupus erythematosus: effect of desamino D-arginine vasopressin infusion. Br. J. Rheumatol. 26: 262–266, 1987.PubMedCrossRefGoogle Scholar
  5. Blake, D.R., Winyard, P., Scott, D.G.I., Brailsford, S., Blann, A. and Lunec, J. Endothelial cell cytotoxicity in inflammatory vascular diseases–the possible role of oxidized lipoproteins. Ann. Rheum. Dis. 44: 176–182, 1985.PubMedCrossRefGoogle Scholar
  6. Bodolay, E., Bojan, F., Szegedi, G., Stenszky, V. and Farid, N.R. Cytotoxic endothelial cell antibodies in mixed connective tissue disease. Immunol. Lett. 20: 163–168, 1989.PubMedCrossRefGoogle Scholar
  7. Botazzo, G.F., Pujol-Borrell, R., Hanafusa, T. and Feldmann, M. Role of aberrant HLA-DR expression and antigen presentation in induction of endocrine autoimmunity. Lancet ii: 1115–1119, 1983.CrossRefGoogle Scholar
  8. Brasile, L., Galouzis, T., Clarke, J. and Cerilli, J. Clinical significance of the vascular endothelial cell antigen system–evidence for genetic linkage between the endothelial cell antigen system and the major histocompatibility complex. Transpl. Proc. 17: 2318–2321, 1985.Google Scholar
  9. Brasile, L., Kremer, J.M., Clarke, J. and Cerilli, J. Identification of an autoantibody to vascular endothelial cell-specific antigens in patients with systemic vasculitis. Am. J. Med 87: 74–80, 1989.PubMedCrossRefGoogle Scholar
  10. Breedveld, F.C., Heurkens, A.H.M., Lafeber, J.M., Van Hinsbergh, V.W.M. and Cats, A. Immune complexes in sera from patients with rheumatoid vasculitis induce polymorphonuclear cell-mediated injury to endothelial cells. Clin. Immunol. Immunopathol. 48: 202–213, 1988.PubMedCrossRefGoogle Scholar
  11. Burns, E.R. and Zucker-Franklin, D. Pathologic effects of plasma from patients with thrombotic thrombocytopenia purpura on platelets and cultured vascular endothelial cells. Blood 60: 1030–1037, 1982.PubMedGoogle Scholar
  12. Byron, M.A., Allington, M.J., Chapel, H.M., Mowat, A.G. and Cederholm-Williams, S.A. Indications of vascular endothelial cell dysfunction in systemic lupus erythematosus. Ann. Rheum. Dis. 46: 741–745, 1987.PubMedCrossRefGoogle Scholar
  13. Camussi, G., Caldwell, B., Andres, G. and Brentjens, J.R. Lung injury mediated by antibodies to endothelium. Am. J. Pathol. 127: 216–228, 1987.PubMedGoogle Scholar
  14. Cariou, R., Tobelem, G., Bellucci, S., Soria, J., Soria, C., Maclouf, J. and Caen, J. Effects of lupus anticoagulant on antithrombogenic properties of endothelial cells–inhibition of thrombomodulin-dependent Protein C activation. Thrombos. Haemostas. 60: 54–58, 1988.Google Scholar
  15. Carreras, L.O., Defreyn, G., Machin, S.J., Vermylen, J., Deman, R., Spitz, B. and Van Assche, A. Arterial thrombosis, intrauterine death and lupus anticoagulant: detection of immunoglobulin interfering with prostacyclin formation. Lancet i: 244–246, 1981a.Google Scholar
  16. Carreras, L.O., Defreyn, G., Van Houtte, E., Vermylen, J. and Van Assche, A. Prostacyclin and pre-eclampsia. Lancet i:442, 198lb.CrossRefGoogle Scholar
  17. Cerilli, J., Brasile, L. and Karmody, A. Role of the vascular endothelial cell antigen system in the etiology of atherosclerosis. Ann. Surg. 202: 329–334, 1985a.CrossRefGoogle Scholar
  18. Cerilli, J., Brasile, L., Galouzis, T., Lempert, N. and Clarke, J. The vascular endothelial cell antigen system. Transplantation 39: 286–289, 1985b.CrossRefGoogle Scholar
  19. Cines, D.B., Lyss, A.P., Bina, M., Corkey, R., Kefalides, N.A. and Friedman, H.M. Fc and C3 receptors induced by Herpes simplex virus on cultured human endothelial cells. J. Clin. Invest. 69: 123–128, 1982.PubMedCrossRefGoogle Scholar
  20. Cines, D.B., Lyss, A.P., Reeber, M., Bina, M. and Dehoratius, R.J. Presence of complement-fixing anti-endothelial cell antibodies in systemic lupus erythematosus. J. Clin. Invest. 73: 611–625, 1984.PubMedCrossRefGoogle Scholar
  21. Cines, D.B, Tomaski, A. and Tannenbaum, S. Immune endothelial cell injury in heparin-associated thrombo-cytopenia. N. Eng. J. MecL 316: 581–589, 1987.CrossRefGoogle Scholar
  22. Coade, S.B., Van Haaren, E., Loizou, S., Walport, M.J., Denman, A.M. and Pearson, J.D. Endothelial prostacyclin release in systemic lupus erythematosus. Thrombos. Haemostas. 61: 97–100, 1989.Google Scholar
  23. D’Anastasio, C., Impallomeni, M., McPherson, G.A.D., Clements, W.G., Howells, G.L., Brooks, P.A. and Batchelor, J.R. Antibodies against monocytes and endothelial cells in the sera of patients with atherosclerotic peripheral arterial disease. Atherosclerosis 74: 99–105, 1988.PubMedCrossRefGoogle Scholar
  24. Drenk, F. and Deicher, H.R.G. Pathophysiological effects of endothelial cytotoxic activity derived from sera of patients with progressive systemic sclerosis. J. RheumatoL 15: 468–474, 1988.PubMedGoogle Scholar
  25. Etingin, D.R., Silverstein, R.L., Friedman, H.M. and Hajjar, D.P. Viral activation of the coagulation cascade: molecular interactions at the surface of infected endothelial cells. Cell 61: 657–662, 1990.PubMedCrossRefGoogle Scholar
  26. Ferraro, G., Meroni, P.L., Tincani, A., Sinico, A., Barcellini, W., Radice, A., Gregorini, G., Froldi, M., Borghi, M.O. and Balestrieri, G. Anti-endothelial cell antibodies in patients with Wegener’s granulomatosis and micropolyarteritis. Clin. Exp. Immunol. 79: 47–53, 1990.PubMedCrossRefGoogle Scholar
  27. Gordon, J.L. and Pearson, J.D. Responses of endothelial cells to injury. In: Nossel, H.L. and Vogel, H.J. (eds); Pathobiology of the endothelial cell. Academic Press, New York, pp. 433–454, 1982.Google Scholar
  28. Gordon, J.L., Pottinger, B.E., Woo, P., Rosenbaum, J. and Black, C.M. Plasma von Willebrand factor in connective tissue disease. Ann. Rheum. Dis. 46: 491–492, 1987.PubMedCrossRefGoogle Scholar
  29. Hashemi, S., Smith, C.D. and Izaguirre, C.A. Anti-endothelial cell antibodies: detection and characterization using a cellular enzyme-linked immunosorbent assay. J. Lab. Clin. Med. 109: 434–440, 1987.PubMedGoogle Scholar
  30. Hasselaar, P., Derksen, R.H.W.M., Blokzijl, L. and de Groot, P.G. Thrombosis associated with antiphospholipid antibodies cannot be explained by effects on endothelial and platelet prostanoid synthesis. Thromb. Haemostas. 59: 80–85, 1988.Google Scholar
  31. Heurkens, A.H.M., Hiemstra, P.S., Lafeber, G.J.M., Daha, M.R. and Breedveld, F.C. Anti-endothelial cell antibodies in patients with rheumatoid arthritis complicated by vasculitis. Clin. Exp. Immunol. 78: 7–12, 1989.PubMedGoogle Scholar
  32. Holt, C.M, Lindsey, N., Moult, J., Malia, R.G., Greaves, M., Hume, A., Rowell, N.R., Hughes, P. Antibody-dependent cellular cytotoxicity of vascular endothelium: characterization and pathogenic associations in systemic sclerosis. Clin. Exp. Immunol. 78: 359–365, 1989.PubMedGoogle Scholar
  33. Ianaccone, S.T., Bowed, D., Yarom, A. and Ciraolo, G. In vitro study of cytotoxic factors against endothelium in childhood dermatomyositis. Arch. Neurol. 41: 862–864, 1984.CrossRefGoogle Scholar
  34. Kahaleh, M.B., Sherer, G.K. and Leroy, E.C. Endothelial injury in scleroderma. J. Exp. Med. 149: 1326–1335, 1979.PubMedCrossRefGoogle Scholar
  35. Kahaleh, M.B., Osborn, I. and Leroy, E.C. Increased factor VIII/von Willebrand factor antigen and von Willebrand factor activity in scleroderma and Raynaud’s phenomenon. Ann. Intern. Med. 94: 482–484, 1981.PubMedGoogle Scholar
  36. Lang, B.A., Silverman, E.D., Laxer, R.M. and Lau, A.S. Spontaneous tumor necrosis factor production in Kawasaki disease. J. Pediatr. 115: 939–943, 1989.PubMedCrossRefGoogle Scholar
  37. Larsen, E., Celi, A., Gilbert, G.E., Furie, B.C., Erban, J.K., Bonfanti, R. and Wagner, D.D. PADGEM protein: a receptor that mediates the interaction of activated platelets with neutrophils and monocytes. Cell 59: 305–312, 1989.PubMedCrossRefGoogle Scholar
  38. Leung, D.Y.M., Collins, T., Lapierre, L.A., Geha, R.S. and Pober, J.S. Immunoglobulin M antibodies present in the acute phase of Kawasaki syndrome lyse cultured vascular endothelial cells stimulated by gamma interferon. J. Clin. Invest. 77: 1428–1435, 1986a.CrossRefGoogle Scholar
  39. Leung, D.Y.M., Geha, R.F., Newburger, J.W., Burns, J.C., Fiers, W., Lapierre, L.A. and Pober, J.S. Two monokines, interleukin 1 and tumor necrosis factor render cultured vascular endothelial cells susceptible to lysis by antibodies circulating during Kawasaki syndrome. J. Exp. Med 164: 1958–1972, 1986b.CrossRefGoogle Scholar
  40. Leung, D.Y.M., Moake, J.L., Havens, P.L., Kim, M. and Pober, J.S. Lytic anti-endothelial cell antibodies in hemolytic-uraemic syndrome. Lancet ii: 183–186, 1988.Google Scholar
  41. Leung, D.Y.M., Cotran, R.S., Kurt-Jones, E., Burns, J.C., Newburger, J.W. and Pober, J.S. Endothelial cell activation and high interleukin-1 secretion in the pathogenesis of acute Kawasaki disease. Lancet ii: 1298–1302, 1989.CrossRefGoogle Scholar
  42. Libby, P., Salomom, R.N., Payne, D.D., Schoen, F.J. and Pober, J.S. Functions of vascular walls cells related to the development of transplantation-associated atherosclerosis. TranspL Proc. 21: 3677–3684, 1989.Google Scholar
  43. Marks, R.M., Czerniecki, M., Andrews, B.S. and Penny, R. The effects of scleroderma serum on human microvascular endothelial cells. Arthr. Rheum. 31: 1524–1534, 1988.CrossRefGoogle Scholar
  44. Matsuo, S., Fukatsu, A., Taub, M.A., Caldwell, P.R.B., Brentjens, J.R. and Andres, G. Glomerulonephritis induced in rabbits by antiendothelial antibodies. J. Clin. Invest. 79: 1798–1811, 1987.PubMedCrossRefGoogle Scholar
  45. McCarty, G.A., Lister, K.A., Reichlin, M. and McEver, R. Autoantibody to a novel endothelial cell granule membrane protein antigen in vasculitis. Clin. Res. 38: 316A, 1990.Google Scholar
  46. Moraes, J.R. and Stasny, P. A new antigen system expressed in human endothelial cells. J. Clin. Invest. 60: 449–454, 1977.PubMedCrossRefGoogle Scholar
  47. Nakajima, T., Koyama, T., Kakishita, E. and Nagai, K. Inhibitory effects of TTP sera on binding of anti-platelet glycoprotein IIb-Illa monoclonal antibodies to human vascular endothelial cells. Am. J. Hematol. 25: 115–118, 1987.PubMedCrossRefGoogle Scholar
  48. Paul, L.C., Baldwin, W.M. and Van Es, L.A. Vascular endothelial alloantigens in renal transplantation. Transplantation 40: 117–123, 1985.PubMedCrossRefGoogle Scholar
  49. Penning, C.A., Cunningham, J., French, M.A.H., Harrison, G., Rowell, N.R. and Hughes, P. Antibody-dependent cellular cytotoxicity of human vascular endothelium in systemic sclerosis. Clin. Exp. Immunol. 57: 548–556, 1984.PubMedGoogle Scholar
  50. Penning, C.A., French, M.A.H., Rowell, N.R. and Hughes, P. Antibody-dependent cellular cytotoxicity of human vascular endothelium in systemic lupus erythematosus. J. Clin. Lab. Immunol. 17: 125–130, 1985.PubMedGoogle Scholar
  51. Pober, J.S., Collins, T., Gimbrone, M.A., Cotran, R.S., Gitlin, J.D., Fiers, W., Clayberger, C., Kreusky, A.M., Burakoff, S.J. and Reiss, C.S. Lymphocytes recognize human vascular endothelial and dermal fibroblast Ia antigens induced by recombinant immune interferon. Nature 305: 726–729, 1983.PubMedCrossRefGoogle Scholar
  52. Pober, J.S. and Cotran, R.S. Cytokines and endothelial cell biology. Physiological Reviews 70: 427–451, 1990.PubMedGoogle Scholar
  53. Rappaport, V.J., Hirata, G., Yap, H.K. and Jordan, S.C. Anti-vascular endothelial cell antibodies in severe preeclampsia. Am. J. Obstet. Gynecol. 168: 138–146, 1990.Google Scholar
  54. Rosenbaum, J.R., Pottinger, B.E., Woo, P., Black, C.M., Loizou, S., Byron, M.A., Pearson, J.D. Measurement and characterization of circulating anti-endothelial cell IgG in connective tissue diseases. Clin. Exp. Immunol 72: 450–456, 1988.PubMedGoogle Scholar
  55. Russ, G.R., Starr, R., Nicholls, C., Johnson, P. and Day, A. Monoclonal antibodies against antigens on human monocytes. Transpl. Proc. 19: 2882–2884, 1987.Google Scholar
  56. Ryan, U.S., Schultz, D.R. and Ryan, J.W. Fc and C3b receptors on pulmonary endothelial cells. Induction by injury. Science 214:557–558, 1981.PubMedCrossRefGoogle Scholar
  57. Savage, C.O.S. Pottinger, B.E., Gaskin, G., Wickwood, C.M., Pusey, C.D. and Pearson, J.D. Endothelial cell damage in Wegener’s granulomatosis and microscopic polyarteritis: presence of anti-endothelial cell antibodies and their relation to anti-neutrophil cytoplasm antibodies. Clin. Exp. Immunol. (in press), 1991.Google Scholar
  58. Schook, L.B., Wood, N. and Mohanakumar, T. Identification of human vascular endothelial cell/monocyte antigenic system using monoclonal antibodies. Transplantation 44: 412–416, 1987.PubMedCrossRefGoogle Scholar
  59. Shingu, M. and Hurd, E.R. Sera from patients with systemic lupus erythematosus reactive with human endothelial cells. J. Rheumatol. 8: 581–586, 1981.PubMedGoogle Scholar
  60. Summers, G.D., Weiss, J.B. and Jayson, M.I.V. Failure of sera from patients with scleroderma to exhibit cytotoxicity towards human umbilical vein endothelial cells. Rheumatol. Int. 5: 9–13, 1984.PubMedCrossRefGoogle Scholar
  61. Tanaka, N., Tsukada, N., Kar, C-S. and Yanagisawa, N. Antiendothelial cell antibodies and circulating immune complexes in sera of patients with multiple sclerosis. J. Neuroimmunol. 17: 49–59, 1987.PubMedCrossRefGoogle Scholar
  62. Tannenbaum, S.H., Finko, R. and Cines, D.B. Antibody and immune complexes induce tissue factor production by human endothelial cells. J. Immunol. 137: 1532–1537, 1986a.Google Scholar
  63. Tannenbaum, S.H., Barnathan, E., Van der Keyl, H., Kuo, A., Murray, S. and Cines, D.B. Aggregated IgG stimulates the fibrinolytic inhibitory activity of human endothelial cells. Blood 68: (Suppl): 235, 1986b.Google Scholar
  64. Toothill, V.J., Van Mourik, J.A., Niewenhuis, H.K., Metzelaar, M.J. and Pearson, J.D. Characterization of the enhanced adhesion of neutrophil leukocytes to thrombinstimulated endothelial cells. J. Immunol. 145: 283–291, 1990.PubMedGoogle Scholar
  65. Tsukada, N., Inoue, A., Yanagisawa, N., Behan, W.M.H. and Behan, P.O. Anti-endothelial cell antibody and immune complexes in the sera of animals with acute experimental allergic encephalomyelitis and chronic relapsing experimental allergic encephalomyelitis. J. Neuroimmunol. 12: 89–97, 1986.PubMedCrossRefGoogle Scholar
  66. Uchmann, B., Bang, N.U., Rathbun, M.J., Fineberg, N.S., Davidson, J.K. and Fineberg, S.E. Effect of insulin immune complexes on human blood monocyte and endothelial cell procoagulant activity. J Lab. Clin. Mect 112: 652–659, 1988.Google Scholar
  67. Van Mourik, J.A., Von dem Borne, A.E.G.K. and Giltay, J.G. Pathophysiological significance of integrin expression by vascular endothelial cells. Biochem. Pharmacol. 39: 233–239, 1990.PubMedCrossRefGoogle Scholar
  68. Vismara A, Meroni PL, Tincani A, Harris, E.N., Barcellini, W., Brucato, A., Khamashta, M., Hughes, G.R.V., Zanussi, C. and Balestrieri, G. Relationship between anti-cardiolipin and anti-endothelial cell antibodies in systemic lupus erythematosus. Clin. Exp. Immunol. 74: 247–253, 1988.PubMedGoogle Scholar
  69. Walker, T.S., Triplett, D.A., Javed, N. and Musgrave, K. Evaluation of lupus anticoagulants: antiphospholipid antibodies, endothelium associated immunoglobulin, endothelial prostacyclin secretion, and antigenic Protein S levels. Thrombos. Res. 51: 267–281, 1988.CrossRefGoogle Scholar
  70. Wood, N.L., Schook, L.B., Studer, E.J. and Monaakumar, T. Biochemical characterization of human vascular endothelial cell-monocyte antigens defined by monoclonal antibodies. Transplantation 45: 787–792, 1988.PubMedCrossRefGoogle Scholar
  71. Yap, H.K., Sakai, R.S., Bahn, L., Rappaport, V., Woo, K.T., Ananthuraman, V., Lim, C.H., Chiang, G.S.C. and Jordan, S.C. Anti-vascular endothelial cell antibodies in patients with IgA nephropathy: frequency and clinical significance. Clin. Immunol. Immunopathol. 49: 450–462, 1988.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1991

Authors and Affiliations

  • Jeremy D. Pearson
    • 1
  1. 1.Section of Vascular BiologyMRC Clinical Research CentreMiddlesexUK

Personalised recommendations